Mia's Feed
Medical News & Research

FDA Warning: Peanuts Detected in Certain Ritz Cracker Sandwiches Prompting Recall

FDA Warning: Peanuts Detected in Certain Ritz Cracker Sandwiches Prompting Recall

Share this article

The FDA has issued a risk warning and recall for certain Ritz cracker sandwiches due to undeclared peanuts, posing a serious allergy risk. Consumers should check labels carefully.

2 min read

The U.S. Food and Drug Administration (FDA) has issued a risk warning concerning specific Ritz cracker sandwich products due to the potential presence of undeclared peanuts, a major allergen. This alert follows a voluntary recall announced by Mondelēz Global LLC on July 8, 2025. The recall affects several product sizes, including the Ritz Peanut Butter Cracker Sandwiches in 8-pack, 20-pack, and 224-case quantities, as well as the Ritz Filled Cracker Sandwich 20-count variety pack.

The recall was initiated after the discovery that packaging films used for wrapping individual peanut butter products may contain defects caused by a supplier error. While the outer cartons were correctly labeled to indicate the presence of peanuts, some individual packs were mislabeled as cheese sandwiches. Consumers with peanut allergies are strongly advised not to consume these products, which could cause serious or life-threatening allergic reactions such as hives, lip swelling, or anaphylaxis.

To date, no injuries or illnesses have been reported. The affected products have specific UPC codes and best-by dates ranging from November 2025 to January 2026. These products were sold nationwide at retail stores.

The allergen labeling error posed a serious health risk to individuals allergic to peanuts, making it crucial for consumers to check product labels carefully. Mondelēz Global LLC has assured that corrective actions are underway to prevent future issues.

For those who purchased these products and have peanut allergies, it is recommended to contact the company at 844-366-1171 for further assistance. Consumers are also encouraged to learn more about peanut allergies through reputable sources such as the American Academy of Allergy, Asthma & Immunology.

Source: https://medicalxpress.com/news/2025-07-ritz-fda-issues-due-undeclared.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Study Warns That Cutting SNAP Benefits Will Increase Food Insecurity Among Families

A new study warns that proposed reductions in SNAP benefits could lead to increased food insufficiency and financial hardship among millions of families relying on this vital program.

Using England's Diabetes Prevention Model to Inspire Canadian Initiatives

Canada aims to emulate England's successful diabetes prevention programs by launching community-based initiatives across provinces, potentially reducing cases and healthcare costs through proven diet and exercise strategies.

Gene Therapy Significantly Enhances Quality of Life for Patients with Sickle Cell Disease and Beta Thalassemia

Gene therapy with exagamglogene autotemcel (exa-cel) has demonstrated remarkable and lasting improvements in quality of life for patients with sickle cell disease and beta thalassemia, offering new hope for long-term health and daily living.

Impact of Parental Substance Use Disorder on Millions of U.S. Children

Nearly 19 million children in the U.S. live with parents suffering from substance use disorder, leading to significant mental health and behavioral risks. Recent studies highlight the urgent need for better screening and intervention strategies.